“Real world” outcome of lenalidomide plus dexamethasone in the setting of recurrent and refractory multiple myeloma: Extended follow-up of a retrospective multicenter study by the “rete ematologica pugliese”

Mele, G.; Melpignano, A.; Quarta, G.; Palumbo, G.; Capalbo, S.; Falcone, A.; Cascavilla, N.; Palazzo, G.; Mazza, P.; Iannitto, E.; Curci, P.; Rizzi, R.; Specchia, G.; Rossini, B.; Pavone, V.; Ria, R.; Vacca, A.; Buquicchio, C.; Tarantini, G.; Minoia, C.; Guarini, A.; Ditonno, P.; Polimeno, G.; Reddiconto, G.; Di Renzo, N.

Published in

Elsevier, Leukemia Research, 3(39), p. 279-283, 2015

DOI: 10.1016/j.leukres.2014.12.007

Tools

Export citation

Search in Google Scholar

“Real world” outcome of lenalidomide plus dexamethasone in the setting of recurrent and refractory multiple myeloma: Extended follow-up of a retrospective multicenter study by the “rete ematologica pugliese”

Journal article published in 2015 by G. Mele, A. Melpignano, G. Quarta, G. Palumbo, S. Capalbo, A. Falcone, N. Cascavilla, G. Palazzo, P. Mazza, E. Iannitto, P. Curci, R. Rizzi, G. Specchia, B. Rossini, V. Pavone and other authors.

This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Preprint: archiving allowed

Upload

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by

Published in

Links

Tools

“Real world” outcome of lenalidomide plus dexamethasone in the setting of recurrent and refractory multiple myeloma: Extended follow-up of a retrospective multicenter study by the “rete ematologica pugliese”